These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28674304)

  • 1. [Current Status of Doping in Japan Based on Japan Anti-Doping Disciplinary Panels of the Japan Anti-Doping Agency (JADA): A Suggestion on Anti-Doping Activities by Pharmacists in Japan].
    Imanishi T; Kawabata T; Takayama A
    Yakugaku Zasshi; 2017; 137(7):883-891. PubMed ID: 28674304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current situation and measures to promote anti-doping activities in Japan].
    Asakawa S
    Yakugaku Zasshi; 2011; 131(12):1755-6. PubMed ID: 22129872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Doping: effectiveness, consequences, prevention].
    Guezennec CY
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):33-41. PubMed ID: 11240405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge of pharmacy students about doping, and the need for doping education: a questionnaire survey.
    Shibata K; Ichikawa K; Kurata N
    BMC Res Notes; 2017 Aug; 10(1):396. PubMed ID: 28800770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-doping reference for pharmacists].
    Kasashi K
    Yakugaku Zasshi; 2009 Dec; 129(12):1475-81. PubMed ID: 19952525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of the role of the sports pharmacist with a model for the prediction of athletes' actions to cope with sickness].
    Yamaguchi T; Horio I; Aoki R; Yamashita N; Tanaka M; Izushi F; Miyauchi Y; Araki H
    Yakugaku Zasshi; 2013; 133(11):1249-59. PubMed ID: 24189566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sports drug testing using complementary matrices: Advantages and limitations.
    Thevis M; Geyer H; Tretzel L; Schänzer W
    J Pharm Biomed Anal; 2016 Oct; 130():220-230. PubMed ID: 27040951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Educational opportunities and anti-doping roles and responsibilities for pharmacists.
    Ambrose PJ
    Yakugaku Zasshi; 2011; 131(12):1761-4. PubMed ID: 22129874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sport-Specific Use of Doping Substances: Analysis of World Anti-Doping Agency Doping Control Tests between 2014 and 2017.
    Aguilar-Navarro M; Salinero JJ; Muñoz-Guerra J; Plata MDM; Del Coso J
    Subst Use Misuse; 2020; 55(8):1361-1369. PubMed ID: 32186429
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular complications of doping products].
    Demoulin R; Poyet R; Capilla E; Tortat AV; Pons F; Brocq FX; Druelle A; Jego C; Foucault G; Cellarier GR
    Ann Cardiol Angeiol (Paris); 2018 Nov; 67(5):365-369. PubMed ID: 30290907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What the Japan Cycling Federation hopes to accomplish in cooperation with pharmacists in doping and implementing effective anti-doping controls?].
    Sakamoto Y
    Yakugaku Zasshi; 2011; 131(12):1747-9. PubMed ID: 22129870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2010 Apr; 2(4):149-61. PubMed ID: 20376830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Stimulants and Narcotics by Liquid Chromatography-Tandem Mass Spectrometry and Gas Chromatography-Mass Spectrometry for Sports Doping Control.
    Ahrens BD; Kucherova Y; Butch AW
    Methods Mol Biol; 2016; 1383():247-63. PubMed ID: 26660193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008].
    Thevis M; Hemmersbach P; Geyer H; Schänzer W
    Med Klin (Munich); 2009 Dec; 104(12):918-24. PubMed ID: 20039158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Doping in sport].
    Schänzer W; Thevis M
    Med Klin (Munich); 2007 Aug; 102(8):631-46. PubMed ID: 17694283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of prohibited substances by liquid chromatography tandem mass spectrometry for sports doping control.
    Ahrens BD; Starcevic B; Butch AW
    Methods Mol Biol; 2012; 902():115-28. PubMed ID: 22767112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Doping].
    Kawahara T
    Nihon Rinsho; 2000 Sep; 58 Suppl():162-6. PubMed ID: 11085108
    [No Abstract]   [Full Text] [Related]  

  • 19. [Doping--also a problem in general practice?].
    Dickhuth HH; Berg A; Baumstark M; Rokitzki L; Huonker M; Keul J
    Fortschr Med; 1989 Sep; 107(28):585-8. PubMed ID: 2613151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clarification of the Relationship between Awareness of Doping of Competitive Sports Coaches and Their Instructions to Prevent Doping].
    Yamaguchi T; Horio I; Goto M; Miyauchi Y; Izushi F
    Yakugaku Zasshi; 2016; 136(8):1185-93. PubMed ID: 27477736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.